ready rx semaglutide Ozempic® Compounded GLP-1

For the management of obesity, NICE guideline NG246 (2023) recommends a stepped approach beginning with lifestyle interventions, followed by pharmacological treatment where appropriate

Novo Nordisk published a cross-trial comparison claiming its Wegovy pill produced greater weight loss than Eli Lilly $LLY's newly approved obesity tablet Foundayo, raising the stakes as the two companies compete to shape prescribing trends in the oral GLP-1 market.

PlexusDx Precision Peptide Genetic Test ($99 add-on after month one) identifies your unique GLP1R, GIPR, FTO, and MC4R variantsrevealing how your body naturally responds to semaglutide and metabolic stress

Epub 2023 Jan 12

You may be an ideal candidate for semaglutide treatment if you have a body mass index of 30 or more, or a BMI of at least 27 with conditions such as high blood pressure, type 2 diabetes, or high cholesterol associated with weight gain